Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T17:26:59.910Z Has data issue: false hasContentIssue false
  • English
  • Français

Protection of the Brain After Aneurysmal Rupture – Richardson Lecture

Published online by Cambridge University Press:  18 September 2015

Bryce Weir
Bryce Weir*
Affiliation:
Department of Neurosurgery, University of Chicago, Chicago, Illinois
*
University of Chicago Medical Center, Section of Neurosurgery, 5841 South Maryland Avenue, Chicago. Illinois USA 60637
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The majority of patients survive the first dangerous hours after an aneurysmal rupture. However, many subsequently succumb as a result of a variety of lethal complications. The most important of these develop as sequelae of the initial ischemia, rebleeding and the delayed onset of vasospasm. Some of these deleterious cascades can be aborted. Since the delayed complications such as vasospastic infarction can be accurately predicted, this is one of rare “strokes” that can have pharmacological pre-treatment. The natural history of rebleeding and vasospasm are described as well as their effects on blood flow, oxygen delivery and metabolism. Strategies to ameliorate acute and delayed ischemia and hypoxia are discussed. Finally, potential pharmacotherapies are detailed.

Type
Review Article
Information
Canadian Journal of Neurological Sciences , Volume 22 , Issue 3 , August 1995 , pp. 177 - 186
Copyright
Copyright © Canadian Neurological Sciences Federation 1995

References

1.Espinosa, F, Weir, B, Noseworthy, T.Nonoperative treatment of sub-arachnoid hemorrhage. In: Youmans, JR, (ed), 1990. Neurologic Surgery, 3rd edition. W.B. Saunders Company 1990: 1661–1668.Google Scholar
2.Bhatti, SU, Selman, WR, Lust, D, Ratcheson, RA.Techniques of cerebral protection. Neurosurg Quarterly 1992; 1: 197–213.CrossRefGoogle Scholar
3.Awad, IA, ed. Current management of cerebral aneurysms. Am Assoc Neurol Surg 1993; 1–327.Google Scholar
4.Ratcheson, RA, Wirth, FP (eds.). Ruptured Cerebral Aneurysms: Perioperative Management. Baltimore, William & Wilkins, 1994; 1–208.Google Scholar
5.Öhman, J, Heiskanen, O.Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J. Neurosurg 1989; 70: 55–60.CrossRefGoogle ScholarPubMed
6.Findlay, JM, Weir, BKA.Prevention of aneurysmal subarachnoid hemorrhage. In: Norris, JW, Hachinski, VC, eds. Prevention of Stroke. New York; Springer-Verlag, 1991: 247–260.Google Scholar
7.Haley, EC, Kassell, NF, Turner, JC and the Participants. The International Cooperative Study on the timing of Aneurysm Surgery. The North American Experience. Stroke 1992; 23: 205–214.Google Scholar
8.Smith, RR and Robertson, JT, eds. Subarachnoid Hemorrhage and Cerebrovascular Spasm. Charles C Thomas, Springfield: 1975. (The First International Workshop): 1–268.Google Scholar
9.Wilkins, RH, ed. Cerebral Arterial Spasm. Proceedings of the Second International Workshop, Amsterdam, the Netherlands, 1979. Baltimore, Williams & Wilkins, 1980: 1–699.Google Scholar
10.Weir, B.Aneurysms Affecting the Nervous System, Baltimore: Williams & Wilkins, 1987: 1–671.Google Scholar
11.Wilkins, RH, ed. Cerebral Vasospasm. Proceedings of the III International Symposium in Charlottesville, New York, Raven Press, 1988: 1–522.Google Scholar
12.Sano, K, Takakura, K, Kassell, NF, Sasaki, T, eds. Cerebral Vasospasm. Proceedings of the Fourth International Conference on Cerebral Vasospasm, Tokyo, 1990, Tokyo, University of Tokyo Press, 1990: 1–538.Google Scholar
13.Mayberg, M, ed. Cerebral Vasospasm. Neurosurg Clin North Am 1990; 1: 265–467.Google Scholar
14.Findlay, JM, Macdonald, RL, Weir, BKA.Current concepts of patho-physiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991; 3: 336–361.Google Scholar
15.Findlay, JM, ed. Cerebral Vasospasm. Proceedings of the Fifth International Conference on Cerebral Vasospasm, Edmonton: Elsevier Publishing Company, 1993: 1–508.Google Scholar
16.Weir, B.The pathophysiology of cerebral vasospasm. Br J Neurosurg, 1995 (in press).CrossRefGoogle Scholar
17.Suzuki, J, ed. Treatment of Cerebral Infarction. Wein: Springer-Verlag, 1987: 1–380.Google Scholar
18.Collins, RC, Dobkin, BH, Choi, DW.Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med 1989; 110: 992–1000.CrossRefGoogle ScholarPubMed
19.Weinstein, PR, Faden, AI, eds. Protection of the brain from ischemia. Baltimore: Williams & Wilkins, 1990: 1–307.Google Scholar
20.Öhman, J, Serro, A, Heiskanen, O.Risk factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74; 14–20. 1991.CrossRefGoogle ScholarPubMed
21.Awad I, A.Cerebrovascular occlusive disease and brain ischemia. Am Assoc Neurol Surg 1992; 1–308.Google Scholar
22.Pulsinelli, W.Pathophysiology of acute ischemic stroke. Lancet 1992; 229: 533–536.CrossRefGoogle Scholar
23.Rousseaux, P, Scherpereel, B, Bernard, MH, et al. Fever and cerebral vasospasm in ruptured intracranial aneurysm. Surg Neurol 1980; 14: 459–465.Google Scholar
24.Weir, B, Disney, L, Grace, M, Roberts, P.Daily trends in white blood count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989; 25: 161–165.CrossRefGoogle ScholarPubMed
25.Castillo, J, Martinez, F, Leira, R, et al. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameter. Cerebrovasc Dis 1994; 4: 66–71.CrossRefGoogle Scholar
26.Tereda, T, Hyoutani, G, Uematsu, Y, et al. Hemorrhagic infarction following vasospasm due to ruptured cerebral aneurysms. Neurol Med Chir (Tokyo) 1987; 27: 83–89.CrossRefGoogle Scholar
27.Macdonald, RL, Weir, BKA.A Review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991; 22: 971–982.CrossRefGoogle ScholarPubMed
28.Seiler, RW, Grolimund, P, Aaslid, R, el al. Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage. J Neurosurg 1986: 64: 594–600.CrossRefGoogle ScholarPubMed
29.Grosset, DG, Straityon, J, McDonald, I, et al. Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 1993; 78: 183–187.CrossRefGoogle ScholarPubMed
30.Laumer, R, Steinmeier, R, Gönner, F, et al. Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part, I.Reliability of flow velocities in clinical management. Neurosurgery 1993; 33: 1–9.Google ScholarPubMed
31.Brown, MM, Wade, JPH, Marshall, J.Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man. Brain 1985; 108: 81–93.CrossRefGoogle ScholarPubMed
32.Carpenter, DA, Grubb, RL, Tempel, LW, Powers, WJ.Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 1991; 11: 837–844.CrossRefGoogle ScholarPubMed
33.Hino, A, Veda, S, Misukawa, N, et al. Effect of hemodilution on cerebral hemodynamics and oxygen metabolism. Stroke 1992; 23: 423–426.CrossRefGoogle ScholarPubMed
34.Kusunoki, M, Miura, K, Nakamura, M, et al. Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease. J Cereb Blood Flow Metab 1981; 1: 413–417.CrossRefGoogle ScholarPubMed
35.Siesjö, BK.Pathophysiology and treatment of focal cerebral ischemia. Part 1: Pathophysiology. J Neurosurg 1992; 77: 169–184.CrossRefGoogle Scholar
36.Siesjö, BK.Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337–354.CrossRefGoogle ScholarPubMed
37.Jacewicz, M, Kiessling, M.Pulsinelli, WA.Selective gene expression in focal cerebral ischemia. J Cereb Blood Flow Metab 1986; 6: 263–272.CrossRefGoogle ScholarPubMed
38.Heiss, WD.Experimental evidence of ischemic thresholds and functional recovery. Stroke 1992; 23: 1668–1672.CrossRefGoogle ScholarPubMed
39.Spetzler, RF, Hadley, MN, Raudzens, PA.Barbiturate therapy for brain protection during temporary vascular occlusion. In: Weinstein, PR, Faden, AI, eds. Protection of the Brain from Ischemia. Baltimore; Williams & Wilkins, 1990: 253–288.Google Scholar
40.Todd, MM, Warner, DS.A comfortable hypothesis reevaluated. Cerebral metabolic depression and brain protection during ischemia. Anesthesiology 1992; 76: 161–164.Google ScholarPubMed
41.Batjer, HH.Cerebral protective effects of etomidate: experimental and clinical aspects. Cerebrovasc Brain Metab Rev 1993; 5: 17–32.Google ScholarPubMed
42.Findlay, JM, Weir, BKA, Kassell, NF, et al. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 181–188.CrossRefGoogle ScholarPubMed
43.Mizoi, K, Yoshimoto, T, Takahashi, A, et al. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 1993; 78: 430–37.CrossRefGoogle ScholarPubMed
44.Findlay, JM, Grace, MGA, Weir, BKA.Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 1993; 32: 941–947.CrossRefGoogle ScholarPubMed
45.Zubkov, YN, Nikiforov, BM, Shustin, VA.Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wein) 1984; 70: 65–79.CrossRefGoogle ScholarPubMed
46.Kaku, Y, Yonekawa, Y, Tsukahara, T, et al. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1993; 77: 842–4.CrossRefGoogle Scholar
47.Levy, ML, Gianotta, SL.Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991; 75: 27–31.CrossRefGoogle ScholarPubMed
48.Lee, SH, Heros, RC, Mullan, JC, Korosue, K.Optimum degree of hemodilution for brain protection in a canine model of focal cerebral ischemia. J Neurosurg 1994; 80: 469–475.CrossRefGoogle Scholar
49.Shimoda, M, Oda, S, Tsugane, R, Sato, O.Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 1993; 78: 423–429.CrossRefGoogle ScholarPubMed
50.Hashimoto, M.Yamashita, J, Koide, K, et al. Extreme hemodilution may be harmful in patients with symptomatic vasospasm after subarachnoid hemorrhage. In: Sano, K, Takakura, K, Kassell, NF, Sasaki, T, eds. Cerebral Vasospasm. Tokyo: University of Tokyo Press 1990. 350–351.Google Scholar
51.Darby, JM, Yonas, H, Marks, EC, et al. Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage. J Neurosurg 1994; 80: 857–864.CrossRefGoogle ScholarPubMed
52.Levy, ML, Rabb, CH, Zelman, V, Gianotta, SL.Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993; 79: 494–499.CrossRefGoogle ScholarPubMed
53.Medlock, MD, Dulebohn, SC, Elwood, PW.Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992; 30: 12–16.CrossRefGoogle ScholarPubMed
54.Lanzino, G, Kassell, NF, Germanson, T, et al. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1993; 79: 885–891.CrossRefGoogle ScholarPubMed
55.LeMay, DR, Gehua, L, Zelenock, GBet al. Insulin administration protects neurologic function in cerebral ischemia in rats. Stroke 1988; 19: 1411–1419.CrossRefGoogle ScholarPubMed
56.Marie, C, Bralet, J.Blood glucose level and morphological brain damage following cerebral ischemia. Cerebrovasc Brain Metab Rev 1991; 3: 29–38.Google ScholarPubMed
57.Petruk, KC, West, M, Mohr, G, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo controlled trial. J Neurosurg 1988; 68: 505–517.CrossRefGoogle ScholarPubMed
58.Haley, EC, Kassell, NF, Turner, JC and the Participants: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993; 78: 537–547.CrossRefGoogle ScholarPubMed
59.Shibuya, M, Suzuki, Y, Sugita, K, Saito, I, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J. Neurosurg 1992; 76: 571–577.CrossRefGoogle ScholarPubMed
60.Zager, EL, Ames, A.Reduction of cellular energy requirements. Screening for agents that may protect against CNS ischemia. J Neurosurg 1988; 69: 568–579.CrossRefGoogle ScholarPubMed
61.Karpiak, SE, Tagliavia, A, Wakade, CG.Animal models for the study of drugs in ischemic stroke. Ann Rev Parmacol Toxicol 1989; 29: 403–414.CrossRefGoogle Scholar
62.Fisher, M, Jones, S, Sacco, RL.Prophylactic neuroprotection for cerebral ischemia. Stroke 1994; 25: 1075–1080.CrossRefGoogle ScholarPubMed
63.Grotta, J.The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc Dis 1994; 4: 115–120.CrossRefGoogle Scholar
64.Suzuki, R, Masaoka, H, Hirata, Y, et al. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1992; 77: 96–100.CrossRefGoogle ScholarPubMed
65.Yamaura, I, Tani, E, Maeda, Y, et al. Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 1992; 76: 99–105.CrossRefGoogle ScholarPubMed
66.Kasuya, H, Weir, B, White, DM, Stefansson, K.Mechanisms of oxyhemoglobin-induced release of endothelin-1 from cultivated vascular endothelial cells and smooth muscle cells. J Neurosurg 1993; 79: 892–898.CrossRefGoogle Scholar
67.Rothman, SM, Olney, JW.Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 105–111.CrossRefGoogle ScholarPubMed
68.Choi, DW.Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990; 2: 105–147.Google ScholarPubMed
69.Benveniste, H.The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 1991; 3: 105–147.Google ScholarPubMed
70.Lyden, PD, Hedges, B.Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke 1992; 23: 1463–1470.CrossRefGoogle ScholarPubMed
71.Meadows, ME, Fischer, M, Minematsu, K.Delayed treatment with a noncompetitive NMDA antagonist, CNS-1102, reduces infarct size in rats. Cerebrovasc Dis 1994; 4: 26–31.CrossRefGoogle Scholar
72.Kochanek, PM, Hallenbeck, JM.Polymorphonuclear leucocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367–1379.CrossRefGoogle ScholarPubMed
73.Sakas, DE, Crowell, RM, Kim, K, et al. The perfluorocarbon fluoromethyloadamantane offers cerebral protection in a model of isovolemic hemodilution in rabbits. Stroke 1994; 25: 197–201.CrossRefGoogle Scholar